Risultati della ricerca - Jonas Jögi
- Mostra 1 - 18 risultati su 18
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
<scp>I</scp>ncreased basal ganglia binding of <sup>18</sup><scp>F‐AV‐1451</scp> in patients with progressive supranuclear palsy di Ruben Smith, Martin Schain, Christer Nilsson, Olof Strandberg, Tomas Olsson, Douglas Hägerström, Jonas Jögi, Edilio Borroni, Michael Schöll, Michael Honer, Oskar Hansson
Pubblicazione 2016Artigo -
10
<sup>18</sup>F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease di Niklas Mattsson, Michael Schöll, Olof Strandberg, Ruben Smith, Sebastian Palmqvist, Philip S. Insel, Douglas Hägerström, Tomas Ohlsson, Henrik Zetterberg, Jonas Jögi, Kaj Blennow, Oskar Hansson
Pubblicazione 2017Artigo -
11
Comparing <sup>18</sup> F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease di Niklas Mattsson, Ruben Smith, Olof Strandberg, Sebastian Palmqvist, Michael Schöll, Philip S. Insel, Douglas Hägerström, Tomas Ohlsson, Henrik Zetterberg, Kaj Blennow, Jonas Jögi, Oskar Hansson
Pubblicazione 2018Artigo -
12
Modeling Strategies for Quantification of In Vivo <sup>18</sup>F-AV-1451 Binding in Patients with Tau Pathology di Andreas Hahn, Martin Schain, Maria Erlandsson, Petter Sjölin, Gregory M. James, Olof Strandberg, Douglas Hägerström, Rupert Lanzenberger, Jonas Jögi, Tomas G. Olsson, Ruben Smith, Oskar Hansson
Pubblicazione 2016Artigo -
13
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders di Antoine Leuzy, Ruben Smith, Rik Ossenkoppele, Alexander Santillo, Edilio Borroni, Gregory Klein, Tomas Ohlsson, Jonas Jögi, Sebastian Palmqvist, Niklas Mattsson, Olof Strandberg, Erik Stomrud, Oskar Hansson
Pubblicazione 2020Artigo -
14
Discriminative Accuracy of [<sup>18</sup>F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders di Rik Ossenkoppele, Gil D. Rabinovici, Ruben Smith, Hanna Cho, Michael Schöll, Olof Strandberg, Sebastian Palmqvist, Niklas Mattsson, Shorena Janelidze, Alexander Santillo, Tomas Ohlsson, Jonas Jögi, Richard Tsai, Renaud La Joie, Joel H. Kramer, Adam L. Boxer, Maria Luisa Gorno‐Tempini, Bruce L. Miller, Jae Yong Choi, Young Hoon Ryu, Chul Hyoung Lyoo, Oskar Hansson
Pubblicazione 2018Artigo -
15
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases di Ruben Smith, Francesca Capotosti, Martin Schain, Tomas Ohlsson, Efthymia Vokali, Jérôme Molette, Tanja Touilloux, Valerie Hliva, Ioannis K. Dimitrakopoulos, Andreas Puschmann, Jonas Jögi, Per Svenningsson, Mattias Andréasson, Christine M. Sandiego, David Russell, Patricia Miranda‐Azpiazu, Christer Halldin, Erik Stomrud, Sara Hall, Klas Bratteby, Elina Tampio L’Estrade, Ruth Luthi‐Carter, Andrea Pfeifer, Marie Kosco‐Vilbois, Johannes Streffer, Oskar Hansson
Pubblicazione 2023Artigo -
16
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline di Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot, Ruben Smith, Olof Strandberg, Sebastian Palmqvist, Erik Stomrud, Pontus Tideman, Tomas Ohlsson, Jonas Jögi, Keith A. Johnson, Reisa A. Sperling, Vincent Doré, Colin L. Masters, Christopher C. Rowe, Denise Visser, Bart N. M. van Berckel, Wiesje M. van der Flier, Suzanne L. Baker, William J. Jagust, Heather J. Wiste, Ronald C. Petersen, Clifford R. Jack, Oskar Hansson
Pubblicazione 2022Artigo -
17
The impact of demographic, clinical, genetic, and imaging variables on tau PET status di Rik Ossenkoppele, Antoine Leuzy, Hanna Cho, Carole H. Sudre, Olof Strandberg, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, Tomas Olsson, Jonas Jögi, Erik Stormrud, Young Hoon Ryu, Jae Yong Choi, Adam L. Boxer, Maria Luisa Gorno‐Tempini, Bruce L. Miller, David N. Soleimani‐Meigooni, Leonardo Iaccarino, Renaud La Joie, Edilio Borroni, Gregory Klein, Michael J. Pontecorvo, Michael D. Devous, Sylvia Villeneuve, Chul Hyoung Lyoo, Gil D. Rabinovici, Oskar Hansson
Pubblicazione 2020Artigo -
18
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease di Rik Ossenkoppele, Ruben Smith, Niklas Mattsson, Colin Groot, Antoine Leuzy, Olof Strandberg, Sebastian Palmqvist, Tomas Olsson, Jonas Jögi, Erik Stormrud, Hanna Cho, Young Hoon Ryu, Jae Yong Choi, Adam L. Boxer, Maria Luisa Gorno‐Tempini, Bruce L. Miller, David N. Soleimani‐Meigooni, Leonardo Iaccarino, Renaud La Joie, Suzanne L. Baker, Edilio Borroni, Gregory Klein, Michael J. Pontecorvo, Michael D. Devous, William J. Jagust, Chul Hyoung Lyoo, Gil D. Rabinovici, Oskar Hansson
Pubblicazione 2021Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Disease
Nuclear medicine
Psychology
Pathology
Positron emission tomography
Radiology
Alzheimer's disease
Atrophy
Dementia
Neuroscience
Magnetic resonance imaging
Cognitive decline
Biology
Epilepsy
Progressive supranuclear palsy
Temporal lobe
Amyloid (mycology)
Basal ganglia
Biotechnology
Cardiology
Central nervous system
Chemistry
Cognitive impairment
Cohort
Cortex (anatomy)
Endocrinology
Entorhinal cortex
Geology